Tamoxifen

(asked on 9th January 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what advice the NHS provides on the use of Tamoxifen for menopausal women.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 17th January 2018

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing guidance on the prevention and treatment of ill health and the promotion of good health and social care for the National Health Service. NICE has provided recommendations on the use of tamoxifen in its clinical guideline on ‘Early and locally advanced breast cancer: diagnosis and treatment’ which is currently being updated. The guideline can be found at:

https://www.nice.org.uk/guidance/cg80/chapter/1-Guidance#endocrine-therapy

The Breast Cancer Clinical Expert Group also issued guidance to Cancer Alliances for Provision of Breast Cancer Services, in August 2017. This guidance includes best practice for the provision of tamoxifen, and can be found at:

http://www.yhscn.nhs.uk/media/PDFs/cancer/National%20Optimal%20Pways%202017/Clinical%20Advice%20for%20the%20Provision%20of%20Breast%20Cancer%20Services%20Aug%202017.pdf

Reticulating Splines